Evidence map›Paper›PMID 33622949›Full record

ArticleBMJ open2021

KAP-COVID

Ahmed Taher Masoud, Mohamed Sayed Zaazouee, Sarah Makram Elsayed, Khaled Mohamed Ragab, Esraa M Kamal, Yusra T Alnasser, Ahmed Assar, Anas Z Nourelden, Loai J Istatiah, Mohamed M Abd-Elgawad and 16 more

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Ahmed Taher MasoudFaculty of Medicine, Fayoum University, Fayoum, Egypt.ORCID 0000-0003-4304-6781
Mohamed Sayed ZaazoueeFaculty of Medicine, Al-Azhar University, Assiut, Egypt.
Sarah Makram ElsayedFaculty of Medicine, October 6 University, Giza, Egypt.
Khaled Mohamed RagabFaculty of Medicine, Minia University, Minia, Egypt.
Esraa M KamalFaculty of Medicine, Fayoum University, Fayoum, Egypt.
Yusra T AlnasserFaculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.
Ahmed AssarFaculty of Medicine, Menoufia University, Shebin El-Kom, Egypt.
Anas Z NoureldenFaculty of Medicine, Al-Azhar University, Cairo, Egypt.
Loai J IstatiahFaculty of Medicine, Fayoum University, Fayoum, Egypt.
Mohamed M Abd-ElgawadFaculty of Medicine, Fayoum University, Fayoum, Egypt.
Ahmed T AbdelsattarFaculty of Medicine, Fayoum University, Fayoum, Egypt.
Ahmed A SofyFaculty of Medicine, Fayoum University, Fayoum, Egypt.
Doaa G HegazyGlobal Clinical Scholars Research Training, Harvard Medical School, Boston, Massachusetts, USA.
Victor Z FemíaUniversidade do Vale do Sapucaí, Pouso Alegre, Minas Gerais, Brazil.
Adriana R MendonçaUniversidade do Vale do Sapucaí, Pouso Alegre, Minas Gerais, Brazil.
Fatma M SayedFaculty of Medicine, Fayoum University, Fayoum, Egypt.
Ahmed ElmoursiCollege of Medicine, University of Kentucky, Lexington, Kentucky, USA.
Alaa AlareidiSchool of Environmental and Biological Sciences, Rutgers University, New Brunswick, New Jersey, USA.
Ahmed K Abd-EltawabFaculty of Medicine, Fayoum University, Fayoum, Egypt.
Mohamed AbdelmonemFaculty of Medicine, Fayoum University, Fayoum, Egypt.
Omar M MohammedFaculty of Medicine, Fayoum University, Fayoum, Egypt.
EzzEldeen A DerballaFaculty of Medicine, Fayoum University, Fayoum, Egypt.
Kareem A El-FasCollege of Clinical Pharmacy, King Faisal University, Hofuf, Saudi Arabia.ORCID 0000-0001-8203-8499
Mohamed M Abdel-Daim *Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt.ORCID 0000-0002-4341-2713
Abdelrahman I Abushouk *Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA Abdelrahman.abushouk@med.asu.edu.eg.ORCID 0000-0003-1399-6487
KAP-COVIDGLOBAL Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe adherence to public health recommendations to control COVID-19 spread is influenced by public knowledge, attitudes and practices (KAP). We performed this cross-sectional study to assess the levels and determinants of public KAP towards COVID-19 in a large, multinational sample.

designCross-sectional study (survey).

settingThe questionnaire was distributed to potential respondents via online platforms.

participants71 890 individuals from 22 countries.

methodsWe formulated a four-section questionnaire in English, followed by validation and translation into seven languages. The questionnaire was distributed (May to June 2020) and each participant received a score for each KAP section.

resultsOverall, the participants had fair knowledge (mean score: 19.24±3.59) and attitudes (3.72±2.31) and good practices (12.12±1.83) regarding COVID-19. About 92% reported moderate to high compliance with national lockdown. However, significant gaps were observed: only 68.2% knew that infected individuals may be asymptomatic; 45.4% believed that antibiotics are an effective treatment; and 55.4% stated that a vaccine has been developed (at the time of data collection). 71.9% believed or were uncertain that COVID-19 is a global conspiracy; 36.8% and 51% were afraid of contacting doctors and Chinese people, respectively. Further, 66.4% reported the pandemic had moderate to high negative effects on their mental health. Female gender, higher education and urban residents had significantly (p≤0.001) higher knowledge and practice scores. Further, we observed significant correlations between all KAP scores.

conclusionsAlthough the public have fair/good knowledge and practices regarding COVID-19, significant gaps should be addressed. Future awareness efforts should target less advantaged groups and future studies should develop new strategies to tackle COVID-19 negative mental health effects.

Indexed as

COVID-19AdultCommunicable Disease ControlCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedSARS-CoV-2Surveys and Questionnairesepidemiologypublic healthvirology

Identifiers

PMID33622949
PMCPMC7907623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.